1999-2019: 20 Years of Advocacy in Action MSF’s Access Campaign marks 20 years of work to secure access to affordable medicines, diagnostics and vaccines, and to stimulate medical innovation that answers public health needs JOIN US!
Events | 29 January 2019 MSF statements at WHO Executive Board 144th session UN Photo/Christopher Black MSF representatives are attending the 144th session of the WHO executive board meetings and will be speaking on a number of topics. Our statements Statement | 31 January 2019 Drug-resistant infections 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min Tags WHO Executive Board
Statement | 31 January 2019 Drug-resistant infections 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Antimicrobial resistance 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products - Access to medicines and vaccines 2 min
Statement | 29 January 2019 Research and development 144th WHO EB: Medicines, vaccines and health products: Cancer medicines 2 min
Statement | 30 January 2019 Tuberculosis 144th WHO EB: Follow-up to the high-level meetings of the United Nations General Assembly on health-related issues: Ending tuberculosis 2 min
